Literature DB >> 28232741

Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice.

D Wang1, Y Fløisand2, C V Myklebust1, S Bürgler1,2, A Parente-Ribes1, P O Hofgaard1,3, B Bogen1,3, K Taskén4, G E Tjønnfjord2,5, F Schjesvold1,2, J Dalgaard2,6, A Tveita1, L A Munthe1.   

Abstract

Multiple myeloma (MM) is a plasma cell malignancy where MM cell growth is supported by the bone marrow (BM) microenvironment with poorly defined cellular and molecular mechanisms. MM cells express CD40, a receptor known to activate autocrine secretion of cytokines and elicit proliferation. Activated T helper (Th) cells express CD40 ligand (CD40L) and BM Th cells are significantly increased in MM patients. We hypothesized that activated BM Th cells could support MM cell growth. We here found that activated autologous BM Th cells supported MM cell growth in a contact- and CD40L-dependent manner in vitro. MM cells had retained the ability to activate Th cells that reciprocated and stimulated MM cell proliferation. Autologous BM Th cells supported MM cell growth in xenografted mice and were found in close contact with MM cells. MM cells secreted chemokines that attracted Th cells, secretion was augmented by CD40-stimulation. Within 14 days of culture of whole BM aspirates in autologous serum, MM cells and Th cells mutually stimulated each other, and MM cells required Th cells for further expansion in vitro and in mice. The results suggest that Th cells may support the expansion of MM cells in patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28232741     DOI: 10.1038/leu.2017.69

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  45 in total

Review 1.  The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma.

Authors:  Lori A Ehrlich; G David Roodman
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

Review 2.  TRAF proteins in CD40 signaling.

Authors:  Gail A Bishop; Carissa R Moore; Ping Xie; Laura L Stunz; Zachary J Kraus
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 3.  Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity.

Authors:  Federica Sallusto; Antonio Lanzavecchia
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

4.  Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.

Authors:  Yu-Tzu Tai; Xianfeng Li; Xia Tong; Daniel Santos; Takemi Otsuki; Laurence Catley; Olivier Tournilhac; Klaus Podar; Teru Hideshima; Robert Schlossman; Paul Richardson; Nikhil C Munshi; Mohammad Luqman; Kenneth C Anderson
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

5.  Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells.

Authors:  Dietmar Herndler-Brandstetter; Katja Landgraf; Brigitte Jenewein; Alexandar Tzankov; Regina Brunauer; Stefan Brunner; Walther Parson; Frank Kloss; Robert Gassner; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

6.  CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling.

Authors:  Yu-Tzu Tai; Klaus Podar; Nicholas Mitsiades; Boris Lin; Constantine Mitsiades; Deepak Gupta; Masaharu Akiyama; Laurence Catley; Teru Hideshima; Nikhil C Munshi; Steven P Treon; Kenneth C Anderson
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

7.  Phenotypic difference of normal plasma cells from mature myeloma cells.

Authors:  H Harada; M M Kawano; N Huang; Y Harada; K Iwato; O Tanabe; H Tanaka; A Sakai; H Asaoku; A Kuramoto
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

Review 8.  How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Authors:  Ole Audun Werner Haabeth; Anders Aune Tveita; Marte Fauskanger; Fredrik Schjesvold; Kristina Berg Lorvik; Peter O Hofgaard; Hilde Omholt; Ludvig A Munthe; Zlatko Dembic; Alexandre Corthay; Bjarne Bogen
Journal:  Front Immunol       Date:  2014-04-15       Impact factor: 7.561

9.  Lymphomas can develop from B cells chronically helped by idiotype-specific T cells.

Authors:  Michael M Zangani; Marianne Frøyland; Gao Yue Qiu; Leonardo A Meza-Zepeda; Jeffery L Kutok; Keith M Thompson; Ludvig A Munthe; Bjarne Bogen
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  3 in total

1.  Transcriptional profiling of human intestinal plasma cells reveals effector functions beyond antibody production.

Authors:  Omri Snir; Chakravarthi Kanduri; Knut E A Lundin; Geir Kjetil Sandve; Ludvig M Sollid
Journal:  United European Gastroenterol J       Date:  2019-07-03       Impact factor: 4.623

2.  Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically.

Authors:  Mariaserena Giliberto; Deepak B Thimiri Govinda Raj; Andrea Cremaschi; Sigrid S Skånland; Alexandra Gade; Geir E Tjønnfjord; Fredrik Schjesvold; Ludvig A Munthe; Kjetil Taskén
Journal:  Mol Oncol       Date:  2022-03-12       Impact factor: 6.603

Review 3.  Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.

Authors:  Michael Pisano; Yan Cheng; Fumou Sun; Binod Dhakal; Anita D'Souza; Saurabh Chhabra; Jennifer M Knight; Sridhar Rao; Fenghuang Zhan; Parameswaran Hari; Siegfried Janz
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.